Post

EHA 2024: Monoclonal antibodies continue to dominate multiple myeloma treatments

Many significant Phase I-III studies targeting haematological malignancies, such as multiple myeloma (MM), were presented at the European Hematology Association …

Sarepta’s Elevidys secures US label expansion for DMD

Just a week after Pfizer revealed a Phase III trial failure for its mini-dystrophin gene therapy for Duchenne muscular dystrophy …

Tectonic bets on GPCR heart failure drug following reverse merger with Avrobio

Tectonic Therapeutic has completed a reverse merger with Avrobio and will begin trading on the Nasdaq global market as Tectonic …

WHO warns of “harmful” fake Ozempic in circulation in Americas and Europe

The World Health Organization (WHO) has issued an alert on falsified versions of Novo Nordisk’s blockbuster type 2 diabetes drug …

South Korea seeks to accelerate drug reimbursement administration process

South Korea is moving forward with reforming its national health insurance system to improve patients' access to healthcare support under …